Literature DB >> 16341694

Increased sensitivity of Hep G2 cells toward the cytotoxicity of cisplatin by the treatment of piper betel leaf extract.

Shun-Chieh Young1, Chau-Jong Wang, Jeng-Dong Hsu, Jui-Ling Hsu, Fen-Pi Chou.   

Abstract

Piper betel leaves (PBL) are used in Chinese folk medicine for the treatment of various disorders. PBL has the biological capabilities of de-toxication, anti-oxidation and anti-mutation. In this study we first examined the effect of PBL extract on the activity of Glutathione S-transferase (GST) isoforms, and found that it inhibited total GST and the alpha class of GST (GSTA), but not the pi class of GST (GSTP), and the mu class of GST (GSTM), activity in Hep G2 cells. RT-PCR results verified a reduction in the expression of GSTA1. Next, we examined whether PBL extract could increase the sensitivity of Hep G2 cells to anti-cancer drugs. The data showed that the cytotoxicity of cisplatin was significantly enhanced by the presence of PBL extract, accompanied by a reduction in the expression of multidrug resistance protein 2 (MRP2). These effects of PBL extract were compared to its major constitute, eugenol. Although eugenol decreased MRP2 level more effectively than PBL extract, it exhibited less sensitizing effect. In conclusion, we demonstrated that PBL extract was able to increase the sensitivity of Hep G2 cells to cisplatin via at least two mechanisms, reducing the expression of MRP2 and inhibiting the activity of total GST and the expression of GSTA. The data of this study support an application of PBL as an additive to reduce drug resistance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16341694     DOI: 10.1007/s00204-005-0051-3

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  8 in total

Review 1.  Regulation of hepatic ABCC transporters by xenobiotics and in disease states.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

2.  Piper betle leaf extract enhances the cytotoxicity effect of 5-fluorouracil in inhibiting the growth of HT29 and HCT116 colon cancer cells.

Authors:  Pek Leng Ng; Nor Fadilah Rajab; Sue Mian Then; Yasmin Anum Mohd Yusof; Wan Zurinah Wan Ngah; Kar Yong Pin; Mee Lee Looi
Journal:  J Zhejiang Univ Sci B       Date:  2014-08       Impact factor: 3.066

Review 3.  Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis.

Authors:  Bharat B Aggarwal; Michelle E Van Kuiken; Laxmi H Iyer; Kuzhuvelil B Harikumar; Bokyung Sung
Journal:  Exp Biol Med (Maywood)       Date:  2009-06-02

4.  Improvement of colchicine oral bioavailability by incorporating eugenol in the nanoemulsion as an oil excipient and enhancer.

Authors:  Qi Shen; Ying Wang; Yi Zhang
Journal:  Int J Nanomedicine       Date:  2011-06-20

Review 5.  The Dual Antioxidant/Prooxidant Effect of Eugenol and Its Action in Cancer Development and Treatment.

Authors:  Daniel Pereira Bezerra; Gardenia Carmen Gadelha Militão; Mayara Castro de Morais; Damião Pergentino de Sousa
Journal:  Nutrients       Date:  2017-12-17       Impact factor: 5.717

6.  Transcriptome Analysis Reveals AI-2 Relevant Genes of Multi-Drug Resistant Klebsiella pneumoniae in Response to Eugenol at Sub-MIC.

Authors:  Yi-Ming Wang; Wen-Long Dong; Kokou Ayefounin Odah; Ling-Cong Kong; Hong-Xia Ma
Journal:  Front Microbiol       Date:  2019-05-28       Impact factor: 5.640

7.  Spheroid Culture Differentially Affects Cancer Cell Sensitivity to Drugs in Melanoma and RCC Models.

Authors:  Aleksandra Filipiak-Duliban; Klaudia Brodaczewska; Arkadiusz Kajdasz; Claudine Kieda
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

8.  Bornyl cis-4-Hydroxycinnamate Suppresses Cell Metastasis of Melanoma through FAK/PI3K/Akt/mTOR and MAPK Signaling Pathways and Inhibition of the Epithelial-to-Mesenchymal Transition.

Authors:  Tzu-Yen Yang; Mei-Li Wu; Chi-I Chang; Chih-I Liu; Te-Chih Cheng; Yu-Jen Wu
Journal:  Int J Mol Sci       Date:  2018-07-24       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.